Peptron
Yusong, Taejon-jikhalsi, South Korea
About Peptron
Peptron is a biotech company developing a wide range of peptide and small molecule based drugs to treat chronic and life-threatening disorders. Its initial focus is to provide long-term cure for neurodegenerative, cancer and endocrine related diseases. Peptron integrates the extensive experience of peptide research, drug development and expertise in drug delivery technologies for more than 15 years combined with a patients-focused approach driven by excellence.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2014)
- Website: peptron.co.kr
- Phone: 042-360-8880
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/peptron-2508592 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.